We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Previous research in laboratory settings and animal studies suggest that interferon-lambda may help control viruses that cause respiratory illnesses, such as influenza and SARS. Read More
The FDA is working with the Centers for Disease Control and Prevention (CDC) to determine how it will restart routine on-site inspections of drug manufacturing facilities, the agency has announced. Read More
The World Health Organization (WHO) said this week that “potentially positive data” is coming out of early clinical trials of COVID-19 treatments, but it declined to name the specific drugs showing promise. Read More
Oxford University has launched a clinical trial testing existing drugs, including hydroxychloroquine and azithromycin, as preventative COVID-19 treatments in older patients. Read More
After Gilead Sciences’ remdesivir was approved for emergency use on COVID-19 patients, a number of other trials have gotten underway to test the antiviral’s benefits in combination with other drugs. Read More
The Yomi system is indicated for use in assisting with preoperative and intraoperative stages of dental implantation surgery, offering computerized navigation. Read More
The FDA yesterday updated its March guidance on managing clinical trials during COVID-19 by saying that sites can conduct patient visits via video conference with some advance planning. Read More
Sponsors of drugs to treat or prevent COVID-19 should focus on populations that are the hardest hit and least represented in clinical trials, including minorities and the elderly, according to a new FDA guidance released yesterday. Read More